Saudi Arabia Wearable Medical Devices Market Outlook to 2030: Size, Share, Growth and Trends

The Saudi Arabia Wearable Medical Devices Market is valued at USD 368 Mn in 2024 on an industry-revenue, first-sale basis. That base also corresponds to 3.85 Mn units , which implies a market-wide average selling price of about USD 95.6 per unit . The market is already large enough to matter strategically because adoption is no longer limited to discretionary tracking; chronic disease management, vital signs monitoring, and telehealth-linked wearables now account for most of the value pool. Geographically, demand remains urban-led, with Riyadh, Jeddah, and Dammam contributing the majority of purchases and institutional deployments.

The base-case projection takes the Saudi Arabia Wearable Medical Devices Market to USD 991 Mn by 2030 , implying an 18.0% CAGR during 2025-2030 . This trajectory assumes continued CGM expansion, wider RPM use in provider workflows, and steady improvement in product mix toward higher-value clinically validated devices. Volume growth remains strong, but revenue grows faster than units because the category mix shifts toward chronic-care and medically integrated products. In practical terms, the market approaches a billion-dollar revenue pool within the forecast window, which makes Saudi Arabia material for global wearable-medtech allocation decisions.

The fastest profit-pool shift is toward Continuous Glucose Monitoring (CGM) & Insulin Management Devices . That segment starts from USD 74 Mn in 2024 and grows faster than any other major category at 24.5% CAGR . The reason is structural: CGM has recurring sensor economics, high clinical relevance, and stronger switching costs than basic wrist-based wellness devices. As a result, value is shifting away from one-time discretionary purchases and toward repeat-use categories tied to diabetes management and physician-guided monitoring. RPM-linked platforms are the secondary beneficiary because they capture service and analytics layers around device usage.

The main constraint is the combination of import dependence and compliance intensity. Local content in pharmaceutical and medical devices manufacturing was only 15% by year-end 2024 , even though the policy aspiration is 40% by 2030 . That means many advanced wearables still depend on imported technology, exposing suppliers to lead-time risk, inventory planning pressure, and regulatory bottlenecks. At the same time, SFDA licensing, authorization, and post-market obligations raise the fixed-cost threshold for market participation. This does not block growth, but it does favor well-capitalized players with regulatory depth and local operating infrastructure.

Saudi Arabia is the largest market in the selected GCC comparison set. At USD 368 Mn in 2024 , it is materially larger than the estimated USD 142 Mn UAE market and the estimated USD 92 Mn Kuwait market . The gap is explained by larger chronic-disease scale, deeper institutional healthcare infrastructure, and more visible digital-health deployment through health clusters and national virtual-care initiatives. Saudi Arabia also offers stronger scaling conditions because the market is large enough to support both consumer-led and provider-led channels, whereas smaller Gulf markets often remain more skewed toward affluent self-pay demand and narrower hospital procurement pools.

The single most important demand driver is the intersection of diabetes prevalence and digital care integration. Saudi Arabia had 5.3 million adults with diabetes in 2024 , and Seha Virtual Hospital recorded 11.5 million virtual clinic appointments in 2025 . That combination matters because it links a large monitored patient base with an operating digital-care architecture capable of absorbing wearables into routine practice. If those two variables continue to move together, the market will increasingly favor CGM, cardiac monitoring, and RPM devices over basic wellness hardware. That is the shift most likely to determine both market size and margin quality.